Fujifilm kickstarts new breast cancer screening awareness campaign

Fujifilm Medical Systems U.S.A. has announced a new breast cancer screening awareness campaign focused on early detection. The “Aspire to Be Fearless” campaign officially began June 12, when the company supported an educational event in Portland, that included presentations from numerous specialists.

At the center of this new campaign is a mobile mammography vehicle that will be traveling throughout the United States to spread Fujifilm’s message. The vehicle includes a waiting room, dressing room and the latest breast imaging solutions from Fujifilm. 

“Fujifilm is partnering with women's imaging providers all around the U.S. to enhance women's access to mammograms and educate community members on the importance of annual screening for early detection,” Rick Banner, senior director of marketing for Fujfilm, said in a prepared statement.

“Breast cancer is one of the most feared cancers among women and some women may feel so apprehensive that they put off their breast exams,” Susan Crennan, women's health product marketing manager for Fujifilm, said in the same statement. “The Aspire to Be Fearless campaign is designed to educate women on the importance of screening and to increase access to breast health exams for women across the country. Through outreach and collaboration with women's health leaders, we are hoping to empower women to be fearless in their approach to their breast health. The 18-month, 48-state campaign will be a collaborative effort between Fujifilm and trusted local women's imaging clinicians to provide services and invaluable information about the importance of early detection."

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The ACR hopes these changes, including the addition of diagnostic performance feedback, will help reduce the number of patients with incidental nodules lost to follow-up each year.

And it can do so with almost 100% accuracy as a first reader, according to a new large-scale analysis.

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.